×
About 2,013 results

ALLMedicine™ Androgenetic Alopecia Center

Research & Reviews  594 results

The first broad replication study of SNPs and a pilot genome-wide association study for...
https://doi.org/10.1111/jocd.15187
Journal of Cosmetic Dermatology; Kim IY, Kim JH et. al.

Jun 28th, 2022 - Many candidate genes for androgenetic alopecia (AGA) have been identified in studies of the Caucasians and some Asian populations. This study aimed to confirm the known susceptibility genes reported in previous studies and find additional candidat...

A Study of Combination Unilateral Subcutaneous Botulinum Toxin A Treatment for Androgen...
https://doi.org/10.1111/jocd.15179
Journal of Cosmetic Dermatology; Tian K, Gao S et. al.

Jun 26th, 2022 - To observe the efficacy of unilateral subcutaneous injection of botulinum toxin A combined with finasteride and minoxidil in the treatment of androgenic alopecia. Thirty-seven patients with androgenic alopecia were treated with finasteride and min...

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029
https://clinicaltrials.gov/ct2/show/NCT05428449

Jun 23rd, 2022 - A randomized, double-blind, Placebo-controlled, parallel group, dose escalation study to evaluate the safety, tolerability and pharmacokinetics (PK) of GT20029 following topical single ascending dose in healthy subjects and multiple ascending dose...

Hair disorder treatments are evolving
https://www.mdedge.com/dermatology/article/255473/hair-nails/hair-disorder-treatments-are-evolving
Kathleen Doheny

Jun 15th, 2022 - “No matter who the patient is, whether a child, adolescent, or adult, the key to figuring out hair disease is getting a good history,” Maria Hordinsky, MD, professor and chair of the department of dermatology at the University of Minnesota, Minnea.

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection...
https://doi.org/10.1111/1346-8138.16475
The Journal of Dermatology; Ohyama M, Matsudo K et. al.

May 29th, 2022 - Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the World Health Organization, and COVID-19 continues to have a major impact on society. Numerous studies have re...

see more →

Guidelines  2 results

Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss...
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.

Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Guidelines for management of androgenetic alopecia based on BASP classification--the As...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.

Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

see more →

Drugs  37 results see all →

Clinicaltrials.gov  106 results

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029
https://clinicaltrials.gov/ct2/show/NCT05428449

Jun 23rd, 2022 - A randomized, double-blind, Placebo-controlled, parallel group, dose escalation study to evaluate the safety, tolerability and pharmacokinetics (PK) of GT20029 following topical single ascending dose in healthy subjects and multiple ascending dose...

Activated PRP for Treatment of Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT05348343

May 25th, 2022 - A clinical trial to assess the effects and safety of PRP activated with pulsed electrical fields (PEFA-PRP) compared with unactivated PRP when used to treat AGA. The design of this small-scale, phase 1b/2a clinical trial is to demonstrate that pul...

CU-40101-101 Following a Fixed-volume Topical Single Administration in Healthy Male Subjects With Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT05380427

May 18th, 2022 - To evaluate the safety and tolerability of TDM-105795 administered topically in healthy male subjects with androgenetic alopecia(AGA ). To evaluate the pharmacokinetics (PK)/Pharmacodynamics (PD) of TDM-105795 following administration of a single ...

Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
https://clinicaltrials.gov/ct2/show/NCT05369481

May 11th, 2022 - Androgenetic alopecia may affect self-esteem and quality of life in several affected individuals. There are two FDA-approved drugs for pattern baldness: topical minoxidil and finasteride, both of which require at least a 4- to 6-month trial before...

Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
https://clinicaltrials.gov/ct2/show/NCT05365360

May 9th, 2022 - Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medications for AGA are topical minoxidil and oral fin...

see more →

News  65 results

Hair disorder treatments are evolving
https://www.mdedge.com/dermatology/article/255473/hair-nails/hair-disorder-treatments-are-evolving
Kathleen Doheny

Jun 15th, 2022 - “No matter who the patient is, whether a child, adolescent, or adult, the key to figuring out hair disease is getting a good history,” Maria Hordinsky, MD, professor and chair of the department of dermatology at the University of Minnesota, Minnea.

Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
https://www.mdedge.com/dermatology/article/252003/acne/spironolactone-not-linked-increased-cancer-risk-systematic-review
Christine Kilgore

Feb 22nd, 2022 - Spironolactone was not associated with any meaningful increase in the risk of breast cancer or other solid organ cancers in a systematic review and meta-analysis covering seven observational studies and a total population of over 4. 5 million peopl.

Male Alopecia Agents Ranked by Efficacy in Meta-Analysis
https://www.medscape.com/viewarticle/968276

Feb 10th, 2022 - In the treatment of male androgenetic alopecia (AGA), low-dose dutasteride (0.5 mg/d), used off label in the US, tops a ranking of the most commonly used oral and topical agents in a new meta-analysis. While up to 90% of men experience AGA in thei...

Hair Loss Drugs Ranked in Order of Efficacy
https://www.medpagetoday.com/dermatology/generaldermatology/97062

Feb 7th, 2022 - The 5-alpha reductase inhibitor (5-ARI) dutasteride (Avodart) likely is the most efficacious among the three drugs currently used to treat androgenetic alopecia (AGA), or male pattern baldness, according to a network meta-analysis. Overall rank fo...

Common Finding Identified in Patients With Persistent Chemotherapy-Induced Alopecia
https://www.medscape.com/viewarticle/962256

Nov 4th, 2021 - Hair follicle miniaturization was a prominent feature of persistent chemotherapy-induced alopecia (pCIA) in breast cancer survivors who presented to four specialty hair clinics, and treatment with minoxidil (sometimes with antiandrogen therapy) wa...

see more →

Patient Education  1 results see all →